The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
D
|
Dong In Entech Co Ltd
KRX:111380
|
KR |
|
Deutsche Bank AG
NYSE:DB
|
DE |
|
NexTone Inc
TSE:7094
|
JP |
|
J
|
J.M. Smucker Co
DUS:JM2
|
US |
|
iomart group PLC
OTC:IMRTF
|
UK |
|
Distribution Solutions Group Inc
F:LW2
|
US |
|
Asset Plus Ltd
NZX:APL
|
NZ |
|
R
|
Ryman Healthcare Ltd
OTC:RYHTY
|
NZ |
|
Diversified Energy Company PLC
NYSE:DEC
|
US |
|
Q
|
Qualcomm Inc
XMUN:QCI
|
US |
|
P
|
Photronics Inc
XMUN:PQ2
|
US |
|
T
|
TWOSTONE&Sons Inc
TSE:7352
|
JP |
|
Kimberly-Clark de Mexico SAB de CV
OTC:KCDMY
|
MX |
|
Crescent Biopharma Inc
F:C68
|
US |
|
Maple Gold Mines Ltd
XTSX:MGM
|
CA |
|
G
|
Gelsenwasser AG
DUS:WWG
|
DE |
|
W
|
Wells Fargo & Co
XMUN:NWT
|
US |
|
AXA SA
MIL:1CS
|
FR |
|
Roche Holding AG
OTC:RHHBY
|
CH |
|
A
|
Argenta Silver Corp
OTC:AGAGF
|
CA |
|
M
|
Morimatsu International Holdings Co Ltd
F:1S5
|
CN |
|
Orora Ltd
ASX:ORA
|
AU |
|
S
|
Synopsys Inc
LSE:0LBP
|
US |
|
Grupo Aeroportuario del Pacifico SAB de CV
BMV:GAPB
|
MX |
Dong In Entech Co Ltd (111380)’s 12-month stock price forecast through October 2027 has a consensus target of ₩19 890, implying 54% upside. The forecast is based on price targets from 3 Wall Street analysts.
Past growth per year Not enough data
Average annual growth cannot be calculated for these periods.
Explore analyst estimates, growth and forecast ranges.
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
According to Wall Street analysts, the average 1-year price target for Dong In Entech Co Ltd is 19 890 KRW with a low forecast of 19 190 KRW and a high forecast of 21 000 KRW.
Over the last 4 years, the compound annual growth rate for Revenue has been 10%. The projected CAGR for the next 3 years is 8%.
Over the last 4 years, the compound annual growth rate for Operating Income has been 5%. The projected CAGR for the next 3 years is 16%.
Over the last 4 years, the compound annual growth rate for Pre-Tax Income has been 0%. The projected CAGR for the next 3 years is 25%.
Over the last 4 years, the compound annual growth rate for Net Income has been -6%. The projected CAGR for the next 3 years is 25%.
AI-generated answers can contain mistakes, outdated facts, or incomplete information. Always verify important details before making decisions.
The AI Assistant is designed for research and education. It does not provide personalized investment, legal, or tax advice.
We rebuilt our DCF valuation models from the ground up and upgraded how Intrinsic Value is calculated. Alpha Spread now selects the method that best fits each company.
You can now see how the new methodology performed across thousands of stocks on our new Valuation Backtest page. We update the results at the end of every month.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
Stock intrinsic value is the real worth of a company's stock, based on its financial health and performance.
Instead of looking at the stock's current market price, which can change due to people's opinions and emotions, intrinsic value helps us understand if a stock is truly a good deal or not.
By focusing on the company's actual financial strength, like its earnings and debts, we can make better decisions about which stocks to buy and when.
Read more